Zealand Pharma will soon launch first drug

Analyst estimates that Zealand Pharma's recently approved rescue pen Zegalogue can generate billion-kroner income for the Danish biotech company, which is getting ready to take the treatment to market.
Zealand Pharma President & CEO Emmanuel Dulac | Photo: Stine Bidstrup/ERH
Zealand Pharma President & CEO Emmanuel Dulac | Photo: Stine Bidstrup/ERH
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

It won't be long before Zealand Pharma sends a drug on the market for the first time. Analysts deem that this might generate a billion-kroner income, according to Danish newspaper Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading